Japan's Alpha Fusion and Kobe City Medical Center General Hospital establish At-211 investigational drug supply system

Japan's startup Alpha Fusion Inc. has announced a joint initiative with the Kobe City Medical Center General Hospital (K...

October 9, 2025 | Thursday | News
Global Biopharma Industry Navigates Shifting Dynamics and Evolving Regional Trends

The bioscience industry is undergoing significant transformation, shaped by global trends and regional dynamics while si...

October 8, 2025 | Wednesday | News
Taiwan's Lotus Pharma to commercialise Semaglutide injection for obesity in multiple Asian markets

Taiwan based Lotus Pharmaceutical, a leading global pharmaceutical company, has entered into a License and Supply Agreem...

October 8, 2025 | Wednesday | News
Hikma and Celltrion strengthen partnership to expand biosimilar access in MENA

UK-based Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, and its long-standing partner Celltrion In...

October 8, 2025 | Wednesday | News
RedHill Biopharma signs $1.8 M deal to accelerate Talicia's entry into new Middle East markets

RedHill Biopharma, a US-based specialty biopharmaceutical company, has announced the licensing of Talicia for new Middle...

October 7, 2025 | Tuesday | News
Lupin invests $250 M to build new state-of-the-art manufacturing facility in US

Global pharmaceutical leader Lupin has announced its plans for a new state-of-the-art pharmaceutical manufacturing plant...

October 9, 2025 | Thursday | News
Agilent and Chungnam National University to build Open Biopharma Research Hub in South Korea

Agilent Technologies Inc. has recently announced a strategic partnership with Chungnam National University&nbs...

October 3, 2025 | Friday | News
South Korea's Boryung to acquire global rights to Taxotere from Sanofi for €175 M

South Korea's Boryung Corporation has signed an asset purchase agreement with the global biopharma company Sanofi to acq...

October 6, 2025 | Monday | News
Tanner Pharma Group and UCB Pharma initiate partnership for epilepsy programme in Southeast Asia

Belgium-based UCB Pharma and US-based Tanner Pharma Group have initiated a partnership in Southeast Asia, including ...

October 6, 2025 | Monday | News
Thermo Fisher Scientific announces R&D partnership with AstraZeneca BioVentureHub

The PPD™ clinical research business of Thermo Fisher Scientific, has announced a new research and development (R&a...

October 6, 2025 | Monday | News
AbbVie begins construction on $70 M expansion to increase biologics manufacturing and R&D presence in US

AbbVie has announced the start of construction of a $70 million expansion at its AbbVie Bioresearch Center (ABC) in...

October 1, 2025 | Wednesday | News
Fosun Pharma deepens global layout with new office in Jeddah, Saudi Arabia

The inauguration ceremony for the Fosun Pharma Middle East Office and Fosunhenlius Middle East United Company was recent...

October 1, 2025 | Wednesday | News
Hong Kong's Health Hope Pharma enters into virology deal with Gilead Sciences

Health Hope Pharma (HHP), a clinical-stage oncology biopharma company headquartered in Hong Kong, has entered into ...

September 30, 2025 | Tuesday | News
Glenmark strengthens oncology portfolio with Hengrui’s HER2 targeting ADC for multiple regions

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...

September 24, 2025 | Wednesday | News
UAE unveils strategic initiative at strengthening position as global hub for entrepreneurship

Sheikh Mohammed bin Rashid Al Maktoum, Vice President, Prime Minister, and Ruler of Dubai, has launched “The Emira...

September 23, 2025 | Tuesday | News
Global expansion of Idorsia’s QUVIVIQ continues as Simcere launches in China

Simcere Pharmaceuticals Group has launched QUVIVIQ® (daridorexant) in China. In 2022, Idorsia an...

September 23, 2025 | Tuesday | News
Angelini Pharma secures $550 M deal with Korea's Sovargen for brain health asset

US-based Angelini Pharma, part of the privately owned Angelini Industries, and Sovargen, a South-Korean biotechnology co...

September 23, 2025 | Tuesday | News
Pfizer buys Metsera and its next-generation obesity portfolio for $4.9 B

US-based pharma giant Pfizer Inc. and Metsera, Inc., a startup based in the US, have entered into a definitive agreement...

September 22, 2025 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls